Dr. Anne-Marie Leuck, MD

Dr. Leuck practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Leuck's NPI, 1275728677, was assigned on September 9, 2007. Dr. Leuck holds Minnesota license 54714.

Dr. Leuck's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Leuck's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Leuck is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Leuck to 9 more medical groups, 7 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leuck practices, 10 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Leuck's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Leuck is licensed in Minnesota.

CMS data shows 121 Medicare services from Dr. Leuck across 4 procedure codes in 2024, for 75 Medicare patients. Medicare paid $10,679 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 75 Medicare patients who saw Dr. Leuck in 2024. The largest group is under 65, with 32 patients. 75% of them have high blood pressure, and 61% have mood disorders. 45% are also on Medicaid. Their average risk score is 3.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leuck's median patient age at 64, with 45% women.

In 2024, Dr. Leuck wrote 523 Medicare Part D claims for 52 patients. 77% of them were for generic drugs. CMS names the drug for 351 of them, across 15 drugs with 11 or more claims each, at $319,916 in total drug cost. In 2023, CMS named 302 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Leuck for performance year 2024, reported as part of a group. Dr. Leuck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leuck as offering telehealth.

Dmand AI links 6 papers to Dr. Leuck, published from 2012 to 2023. 2014 was the busiest year, with 2. The most frequent topics are Urinary Tract Infections. Dr. Leuck's most frequent co-authors are Dimitri Maximilian Drekonja, MD, Patricia Ferrieri, MD and Travis Steven Fulk, MD.

CMS Open Payments shows 2 general payments to Dr. Leuck from 2 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 68% of the total. Shionogi Inc paid the most, $35.